Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
- Check16 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check37 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check66 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.